, Tracking Stock Market Picks
Enter Symbol:
China Biologic Products Inc (CBPO) [hlAlert]

up 175.42 %

China Biologic Products Inc (CBPO) rated Outperform with price target $46 by Oppenheimer

Posted on: Friday,  Mar 14, 2014  8:25 AM ET by Oppenheimer

Oppenheimer rated Outperform China Biologic Products Inc (NASDAQ: CBPO) on 03/14/2014, when the stock price was $36.25. Since
then, China Biologic Products Inc has gained 175.42% as of 10/08/2015's recent price of $99.84.
If you would have followed this Oppenheimer's recommendation on CBPO, you would have gained 175.42% of your investment in 573 days.

China Biologic Products, Inc. is a biopharmaceutical company and through its Chinese subsidiaries, Shandong Taibang and Qianfeng, and Huitian, the Company is engaged in the research, development and manufacturing of plasma-based pharmaceutical products in China. It sells human albumin, which represented approximately 49.7% during the year ended December 31, 2009. Human albumin is principally used to increase blood volume while immunoglobulin is used for certain disease preventions and cures. The Company sells human albumin 20%/10ml, 20%/25ml, 20%/50ml, 10%/10ml, 10%/25ml, 10%/50ml and 25%/50ml. It sells the products to customers in the People Republic of China (PRC), mainly hospitals and inoculation centers. In June 2009, it purchased 35% interest in Xi'an Huitian Blood Products Co., Ltd. On December 21, 2009, the Company established Logic Management and Consulting (China) Co., Ltd.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/14/2014 8:25 AM Buy
36.25 46.00
as of 10/17/2014
1 Week down  -0.09 %
1 Month down  -4.13 %
3 Months up  15.48 %
1 YTD up  43.36 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy